Term Sheet Amneal Pharmaceuticals, Inc.Term Sheet • October 18th, 2023 • Patel Chirag K. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 18th, 2023 Company Industry JurisdictionThis Term Sheet (the “Term Sheet”) is entered into as of October 16, 2023, by and among Amneal Pharmaceuticals, Inc., a Delaware corporation (“Old PubCo”), Amneal Pharmaceuticals LLC (“Opco”) and, solely for purposes of the Amneal Group Representative Consent (as defined below), the Amneal Group Representative1, on behalf of the Amneal Legacy Group. Each of Old PubCo and Opco may be referred to herein as a “Party” and collectively as the “Parties”.
Securities Account Sole Control AgreementSecurities Account Sole Control Agreement • September 11th, 2019 • Patel Chirag K. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 11th, 2019 Company Industry JurisdictionAccount Holder/Debtor: Chirag Patel (“Debtor”) Address: 391 Mendham Road Bernardsville, NJ 07924 Telephone: Email: chirag@avtarinvestments.com
October 29, 2024 Amneal Pharceuticals, Inc.Margin Loan Agreement • October 31st, 2024 • Patel Chirag K. • Pharmaceutical preparations
Contract Type FiledOctober 31st, 2024 Company Industry
UBS FINANCIAL SERVICES INC. A C C O U N T C O N T R O L A G R E E M E N TAccount Control Agreement • October 31st, 2024 • Patel Chirag K. • Pharmaceutical preparations • New York
Contract Type FiledOctober 31st, 2024 Company Industry JurisdictionThis Agreement is between UBS Financial Services Inc. (“UBSFS”), the party or parties signing this Agreement as Client where indicated below (together and individually, “Client”), UBS AG Stamford Branch, as administrative agent (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”) and as calculation agent (in such capacity, together with its successors and assigns, the “Calculation Agent” and together with the Administrative Agent, the “Agents”), each of the Lenders (as defined below) listed from time to time on Schedule A hereto, as collateral agent for itself, the Agents and its Agented Lenders (as defined in the Margin Loan Agreement referred to below) (each such Lender listed on Schedule A, in such capacity as collateral agent, referred to individually as a “Secured Party” and, collectively, as the “Secured Parties”).